Clinical Research Directory
Browse clinical research sites, groups, and studies.
Isolated Glenohumeral Corticosteroid Injection Versus Concomitant Capsule Preserving Hydrodilatation
Sponsor: Chuncheon Sacred Heart Hospital
Summary
This clinical trial investigates whether concomitant capsule-preserving hydrodilatation (CSHD) is more effective than isolated glenohumeral corticosteroid injection (CS) in treating shoulder adhesive capsulitis. The main questions it aims to answer are * Is CSHD inferior to CS in immediate pain relief as the solution is diluted? * Is CSHD superior to CS in improving the range of motion as the contracted capsule is dilated? Group CS will receive an ultrasound-guided glenohumeral corticosteroid injection only, with a solution of 5 mL. Group CSHD will receive an ultrasound-guided glenohumeral corticosteroid with hydrodilatation, with a solution of 20 mL. Clinical scores and range of motion will be compared between the groups up to six months post-injection.
Official title: The Efficacy of Single-shot Capsule-preserving Hydrodilatation With Corticosteroids in Treating Adhesive Capsulitis of the Shoulder: A Randomized Controlled Trial Versus Isolated Corticosteroid Injection
Key Details
Gender
All
Age Range
35 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2013-12-05
Completion Date
2015-11-17
Last Updated
2026-07-09
Healthy Volunteers
No
Interventions
Ultrasound-guided glenohumeral space isolated corticosteroid injection
Using a 21-gauge spinal needle, the predefined steroid solution was injected under ultrasound guidance using 5- to 13-MHz linear probe into the glenohumeral space through the posterior approach.
Ultrasound-guided glenohumeral space concomitant hydrodilatation with corticosteroid injection
Using a 21-gauge spinal needle, the predefined steroid solution with additional 15 mL of normal saline was injected under ultrasound guidance using 5- to 13-MHz linear probe into the glenohumeral space through the posterior approach.
1mL of Triamcinolone (40mg/1mL) Injectable Solution
1mL of Triamcinolone 40mg/1mL solution was included in the injection/hydrodilatation regimen.
4mL of Lidocaine 1% Solution Injectable Solution
4mL of 1% Lidocaine solution was included in the injection/hydrodilatation regimen.
15mL of Normal Saline
15mL of 1% Lidocaine solution was included in the hydrodilatation regimen.
Locations (1)
Chuncheon Sacred Heart Hospital
Chuncheon, Gangwondo, South Korea